SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-045963
Filing Date
2019-08-14
Accepted
2019-08-14 17:22:15
Documents
82
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-10357_110q.htm 10-Q 1126863
2 EX-10.1 a19-10357_1ex10d1.htm EX-10.1 426390
3 EX-10.2 a19-10357_1ex10d2.htm EX-10.2 240757
4 EX-10.3 a19-10357_1ex10d3.htm EX-10.3 245484
5 EX-31.1 a19-10357_1ex31d1.htm EX-31.1 10241
6 EX-31.2 a19-10357_1ex31d2.htm EX-31.2 10153
7 EX-32.1 a19-10357_1ex32d1.htm EX-32.1 5650
8 EX-32.2 a19-10357_1ex32d2.htm EX-32.2 5897
15 GRAPHIC g103571kg11i001.jpg GRAPHIC 6222
  Complete submission text file 0001104659-19-045963.txt   7749099

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT ontx-20190630.xml EX-101.INS 1639285
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ontx-20190630.xsd EX-101.SCH 72587
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ontx-20190630_cal.xml EX-101.CAL 40235
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT ontx-20190630_def.xml EX-101.DEF 233753
13 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT ontx-20190630_lab.xml EX-101.LAB 521484
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ontx-20190630_pre.xml EX-101.PRE 408404
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Filer) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36020 | Film No.: 191027657
SIC: 2834 Pharmaceutical Preparations